Sarepta Therapeutics (NASDAQ:SRPT) leads in genetic therapies, contributing to ongoing discussions surrounding the nasdaq ...
News-Medical.Net on MSN
EpilepsyGTx raises $33 million Series A to develop single dose gene therapy for focal refractory epilepsy
EpilepsyGTx, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced it has raised $33 million in a Series A financing ...
Israel is one of the top-ranked countries in the world in genomic research, he declares. “These are people who lead genomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results